Emergent BioSolutions Inc/ US29089Q1058 /
| 2024-05-13 9:59:49 PM | Chg. +1.02 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 5.37USD | +23.45% | 28,324 Turnover: 148,415.10 |
-Bid Size: - | -Ask Size: - | 280.87 mill.USD | - | - |
Assets
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 264.2000 | 313.9790 | 331.8560 | 376.4480 | 407.2100 | ||||||
| Intangible Assets | 30.1000 | 58.3440 | 57.3750 | 33.8650 | 119.5970 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | 513.0870 | 504.9800 | 459.8930 | 584.8170 | ||||||
| Inventories | 14.6000 | 65.6740 | 76.9360 | 74.0020 | 142.8120 | ||||||
| Accounts Receivable | 60.6000 | 58.8340 | 120.7670 | 138.4780 | 143.6530 | ||||||
| Cash and Cash Equivalents | 179.3000 | 280.4990 | 312.7950 | 271.5130 | 178.2920 | ||||||
| Current Assets | 273.1000 | 432.1750 | 538.6120 | 510.2180 | 485.3890 | ||||||
| Total Assets | 626.6000 | 945.2620 | 1,043.5920 | 970.1110 | 1,070.2060 | ||||||
Liabilities
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 27.5000 | 40.9300 | 45.9660 | 34.6490 | 41.7510 | ||||||
| Long-term debt | - | 251 | 253 | 248.0940 | 13.4570 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 1.4900 | - | - | - | - | ||||||
| Liabilities | 137.5000 | 392.0610 | 383.5750 | 373.9060 | 157.8610 | ||||||
| Share Capital | .0370 | .0380 | .0400 | - | - | ||||||
| Total Equity | 489.2000 | 553.2010 | 660.0170 | 596.2050 | 912.3450 | ||||||
| Minority Interests | -.5000 | - | - | - | - | ||||||
| Total liabilities equity | 626.6000 | 945.2620 | 1,043.5920 | 970.1110 | 1,070.2060 | ||||||
Income Statement
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 312.7000 | 450.1380 | 522.7890 | 488.7820 | 560.8730 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 42.8000 | 58.0560 | 96.0390 | 105.5220 | 124.2850 | ||||||
| Interest Income | .1000 | -7.9200 | -5.9510 | -6.5640 | -4.8370 | ||||||
| Income Before Taxes | 43.4000 | 53.0620 | 89.7690 | 99.2210 | 118.6330 | ||||||
| Income Taxes | 13.1000 | 16.3210 | 26.8990 | 36.6970 | 36.0390 | ||||||
| Minority Interests Profit | .9000 | - | - | - | - | ||||||
| Net Income | 31.1000 | 36.7410 | 62.8700 | 51.7760 | 82.5940 | ||||||
Per Share
Cash Flow
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 97 | 112.3180 | 44.4590 | 53.4870 | 208.1390 | ||||||
| Cash Flow from Investing Activities | -67.9000 | -210.0520 | -45.4620 | -76.2570 | -249.9320 | ||||||
| Cash Flow from Financing | 8.6000 | 198.8740 | 33.4490 | -18.6410 | -51.4010 | ||||||
| Decrease / Increase in Cash | 37.7000 | 101.1610 | 32.2960 | -41.2820 | -93.2210 | ||||||
| Employees | 1,353 | 1,280 | 1,292 | 1,098 | 1,256 | ||||||
